Skip to main content
. 2021 May 13;13(10):2352. doi: 10.3390/cancers13102352
CI confidence interval
CT chemotherapy
DURVA durvalumab
ICI immune checkpoint inhibitors
HRT hypofractionated radiotherapy
MDSCs myeloid-derived suppressor cells
NCDB National Cancer Database
NK natural killer
NNT number needed to treat
NOS Newcastle-Ottawa Scale
NSCLC non-small cell lung cancer
OS overall survival
PEMBRO pembrolizumab
PD-1 programmed cell death
RR risk ratio
RT radiotherapy
SBRT stereobody radiotherapy
SE standard errors
SFRT standard fractionated radiotherapy
TAMs tumor-associated macrophages
Treg regulatory T cells